Breaking News Instant updates and real-time market news.

SZGPY

Salzgitter

$3.38 /

+ (+0.00%)

06:34
04/15/21
04/15
06:34
04/15/21
06:34

Salzgitter upgraded to Overweight from Neutral at JPMorgan

JPMorgan analyst Luke Nelson upgraded Salzgitter to Overweight from Neutral with a price target of EUR 28.50, up from EUR 21.50. Apparent demand in key steel consuming markets continues to surprise to the upside, Nelson tells investors in a research note. In Europe, the analyst assumes demand will essentially be back to "pre-COVID-19" levels by the first half of 2022, 12 months than previously expected.

SZGPY Salzgitter
$3.38 /

+ (+0.00%)

03/24/21 Morgan Stanley
Salzgitter upgraded to Equal Weight from Underweight at Morgan Stanley
03/17/21 Deutsche Bank
Salzgitter price target raised to EUR 22 from EUR 20 at Deutsche Bank
02/23/21 Baader Helvea
Salzgitter upgraded to Buy from Reduce at Baader Helvea
01/25/21 JPMorgan
Salzgitter upgraded to Neutral from Underweight at JPMorgan

TODAY'S FREE FLY STORIES

Earnings
iRadimed sees Q3 adjusted EPS 16c-17c, two est. 13c » 07:11
07/30/21
07/30
07:11
07/30/21
07:11
IRMD

iRadimed

$34.60 /

-0.69 (-1.96%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

08/03/20 Roth Capital
iRadimed price target lowered to $26 from $30 at Roth Capital
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

Hot Stocks
Enbridge still sees FY21 EBITDA $13.9B-$14.3B » 07:10
07/30/21
07/30
07:10
07/30/21
07:10
ENB

Enbridge

$39.70 /

+0.36 (+0.92%)

Still sees FY21…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

07/20/21 Barclays
Enbridge downgraded to Equal Weight from Overweight at Barclays
07/08/21 Scotiabank
Enbridge price target raised to C$55 from C$54 at Scotiabank
06/30/21 Goldman Sachs
Enbridge upgraded to Neutral from Sell at Goldman Sachs
06/18/21 CIBC
Enbridge price target raised to C$57 from C$52 at CIBC
ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

Recommendations
Mettler-Toledo price target raised to $1455 from $1303 at Baird » 07:10
07/30/21
07/30
07:10
07/30/21
07:10
MTD

Mettler-Toledo

$1,508.23 /

+7.56 (+0.50%)

Baird analyst Catherine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

04/07/21 Baird
Mettler-Toledo assumed with an Outperform at Baird
02/05/21 Wells Fargo
Mettler-Toledo price target raised to $1,300 from $1,100 at Wells Fargo
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

MTD Mettler-Toledo
$1,508.23 /

+7.56 (+0.50%)

Earnings
Hill-Rom raises FY21 adjusted EPS view to $6.08-$6.12 from $ 6.00-$6.10 » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
HRC

Hill-Rom

$136.86 /

+4.17 (+3.14%)

Consensus $6.06. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

07/29/21 KeyBanc
KeyBanc sees a potential acquisition of Hill-Rom 'favorably' for Baxter
07/28/21 KeyBanc
Baxter offer in $150-$165 range would be 'reasonable' for Hill-Rom, says KeyBanc
05/03/21 Baird
Hill-Rom price target raised to $125 from $115 at Baird
02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

Earnings
iRadimed reports Q2 adjusted EPS 14c, two est. 9c » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
IRMD

iRadimed

$34.60 /

-0.69 (-1.96%)

Reports Q2 revenue $9.8M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

08/03/20 Roth Capital
iRadimed price target lowered to $26 from $30 at Roth Capital
IRMD iRadimed
$34.60 /

-0.69 (-1.96%)

Earnings
Enbridge reports Q2 adjusted EPS 67c, consensus 55c » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
ENB

Enbridge

$39.70 /

+0.36 (+0.92%)

CEO Al Monaco stated,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

07/20/21 Barclays
Enbridge downgraded to Equal Weight from Overweight at Barclays
07/08/21 Scotiabank
Enbridge price target raised to C$55 from C$54 at Scotiabank
06/30/21 Goldman Sachs
Enbridge upgraded to Neutral from Sell at Goldman Sachs
06/18/21 CIBC
Enbridge price target raised to C$57 from C$52 at CIBC
ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

ENB Enbridge
$39.70 /

+0.36 (+0.92%)

Periodicals
Tesla Megapack caught fire at Australia battery project, Electrek reports » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
TSLA

Tesla

$677.35 /

+30.54 (+4.72%)

A Tesla Megapack part of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$677.35 /

+30.54 (+4.72%)

TSLA Tesla
$677.35 /

+30.54 (+4.72%)

07/29/21 DZ Bank
Tesla upgraded to Buy from Sell at DZ Bank
07/28/21 Citi
Tesla price target raised to $209 from $175 at Citi
07/27/21 Needham
Tesla saw improvement on cost structure, valuation still too high, says Needham
07/27/21 Roth Capital
Competitive news flow likely drives Tesla 2H21 volatility, says Roth Capital
TSLA Tesla
$677.35 /

+30.54 (+4.72%)

TSLA Tesla
$677.35 /

+30.54 (+4.72%)

TSLA Tesla
$677.35 /

+30.54 (+4.72%)

TSLA Tesla
$677.35 /

+30.54 (+4.72%)

Recommendations
Gilead price target raised to $84 from $81 at RBC Capital » 07:09
07/30/21
07/30
07:09
07/30/21
07:09
GILD

Gilead

$69.83 /

-0.28 (-0.40%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$69.83 /

-0.28 (-0.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
06/16/21 Roth Capital
JTX-1811 IND-clearance further validates Jounce platform, says Roth Capital
06/15/21 Piper Sandler
Jounce Therapeutics receives $25M milestone from Gilead, says Piper Sandler
04/01/21
Fly Intel: Top five analyst upgrades
GILD Gilead
$69.83 /

-0.28 (-0.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

GILD Gilead
$69.83 /

-0.28 (-0.40%)

Hot Stocks
Capital Product Partners says supply of vessels continues to be very restricted » 07:08
07/30/21
07/30
07:08
07/30/21
07:08
CPLP

Capital Product Partners

$12.21 /

+0.3 (+2.52%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

04/30/21 B. Riley
Capital Product Partners price target raised to $16 from $14 at B. Riley
04/22/21 Jefferies
Jefferies upgrades Capital Product Partners on rising containership values
04/22/21 Jefferies
Capital Product Partners upgraded to Buy from Hold at Jefferies
04/05/21 B. Riley Securities
Capital Product price target raised to $14 from $11 at B. Riley
CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

Earnings
Capital Product Partners reports Q2 EPS $1.89, consensus 55c » 07:07
07/30/21
07/30
07:07
07/30/21
07:07
CPLP

Capital Product Partners

$12.21 /

+0.3 (+2.52%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

04/30/21 B. Riley
Capital Product Partners price target raised to $16 from $14 at B. Riley
04/22/21 Jefferies
Jefferies upgrades Capital Product Partners on rising containership values
04/22/21 Jefferies
Capital Product Partners upgraded to Buy from Hold at Jefferies
04/05/21 B. Riley Securities
Capital Product price target raised to $14 from $11 at B. Riley
CPLP Capital Product Partners
$12.21 /

+0.3 (+2.52%)

Earnings
Hill-Rom sees Q4 adjusted EPS $1.44-$1.48, consensus $1.45 » 07:07
07/30/21
07/30
07:07
07/30/21
07:07
HRC

Hill-Rom

$136.86 /

+4.17 (+3.14%)

Sees Q4 revenue up 6%-7%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

07/29/21 KeyBanc
KeyBanc sees a potential acquisition of Hill-Rom 'favorably' for Baxter
07/28/21 KeyBanc
Baxter offer in $150-$165 range would be 'reasonable' for Hill-Rom, says KeyBanc
05/03/21 Baird
Hill-Rom price target raised to $125 from $115 at Baird
02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

Recommendations
LabCorp price target raised to $330 from $297 at Deutsche Bank » 07:06
07/30/21
07/30
07:06
07/30/21
07:06
LH

LabCorp

$294.69 /

+11.245 (+3.97%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

06:39 Today Mizuho
LabCorp price target raised to $318 from $310 at Mizuho
05/20/21 Argus
LabCorp price target raised to $295 from $270 at Argus
05/18/21 Wells Fargo
Amazon could have interest in diagnostics beyond COVID, says Wells Fargo
05/12/21 Mizuho
LabCorp price target raised to $310 from $267 at Mizuho
LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

LH LabCorp
$294.69 /

+11.245 (+3.97%)

Recommendations
Yum! Brands price target raised to $138 from $120 at BMO Capital » 07:06
07/30/21
07/30
07:06
07/30/21
07:06
YUM

Yum! Brands

$130.31 /

+7.575 (+6.17%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YUM Yum! Brands
$130.31 /

+7.575 (+6.17%)

YUM Yum! Brands
$130.31 /

+7.575 (+6.17%)

07:03 Today Baird
Yum! Brands price target raised to $148 from $130 at Baird
07:02 Today Deutsche Bank
Yum! Brands price target raised to $142 from $113 at Deutsche Bank
06:39 Today RBC Capital
Yum! Brands price target raised to $136 from $124 at RBC Capital
07/26/21 Guggenheim
Yum! Brands started at Buy at Guggenheim on faster global comps
YUM Yum! Brands
$130.31 /

+7.575 (+6.17%)

YUM Yum! Brands
$130.31 /

+7.575 (+6.17%)

YUM Yum! Brands
$130.31 /

+7.575 (+6.17%)

YUM Yum! Brands
$130.31 /

+7.575 (+6.17%)

Hot Stocks
NuVasive receives latest FDA 510(k) clearance for Pulse platform » 07:06
07/30/21
07/30
07:06
07/30/21
07:06
NUVA

NuVasive

$63.08 /

-2.24 (-3.43%)

NuVasive announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NUVA NuVasive
$63.08 /

-2.24 (-3.43%)

NUVA NuVasive
$63.08 /

-2.24 (-3.43%)

07/15/21 Piper Sandler
NuVasive MAGEC ship hold lift positive despite FDA warning, says Piper Sandler
05/06/21 Piper Sandler
NuVasive price target raised to $80 from $75 at Piper Sandler
04/27/21 Truist
NuVasive price target raised to $80 from $68 at Truist
04/05/21 Piper Sandler
FDA appears to approve NuVasive two-level indication, says Piper Sandler
NUVA NuVasive
$63.08 /

-2.24 (-3.43%)

Earnings
Hill-Rom reports Q3 EPS 74c, consensus $1.34 » 07:05
07/30/21
07/30
07:05
07/30/21
07:05
HRC

Hill-Rom

$136.86 /

+4.17 (+3.14%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

07/29/21 KeyBanc
KeyBanc sees a potential acquisition of Hill-Rom 'favorably' for Baxter
07/28/21 KeyBanc
Baxter offer in $150-$165 range would be 'reasonable' for Hill-Rom, says KeyBanc
05/03/21 Baird
Hill-Rom price target raised to $125 from $115 at Baird
02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

HRC Hill-Rom
$136.86 /

+4.17 (+3.14%)

Syndicate
In8bio 4M share IPO priced at $10.00 » 07:05
07/30/21
07/30
07:05
07/30/21
07:05
INAB

In8bio

/

+

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
  • 30
    Jul
  • 13
    Nov
Recommendations
DexCom price target raised to $520 from $460 at Baird » 07:05
07/30/21
07/30
07:05
07/30/21
07:05
DXCM

DexCom

$456.17 /

-3.25 (-0.71%)

Baird analyst Jeff…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

05:24 Today Piper Sandler
DexCom price target raised to $550 from $500 at Piper Sandler
07/21/21 Cowen
DexCom price target lowered to $525 from $540 at Cowen
07/01/21 Piper Sandler
DexCom settlement with Abbott could be lucrative, says Piper Sandler
07/01/21 Stephens
Stephens says DexCom-Abbott 'legal wrangling' unlikely resolved in short-term
DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

DXCM DexCom
$456.17 /

-3.25 (-0.71%)

Recommendations
Edwards Lifesciences price target raised to $113 from $84 at Deutsche Bank » 07:05
07/30/21
07/30
07:05
07/30/21
07:05
EW

Edwards Lifesciences

$111.76 /

+1.65 (+1.50%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

05:21 Today Piper Sandler
Edwards Lifesciences price target raised to $123 from $120 at Piper Sandler
07/27/21 Piper Sandler
Edwards Lifesciences price target raised to $120 from $105 at Piper Sandler
07/23/21 Cowen
Edwards Lifesciences price target raised to $125 from $100 at Cowen
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

EW Edwards Lifesciences
$111.76 /

+1.65 (+1.50%)

Hot Stocks
Greenlane expects KushCo merger to close in Q3 » 07:05
07/30/21
07/30
07:05
07/30/21
07:05
GNLN

Greenlane

$3.68 /

+0.02 (+0.55%)

, KSHB

KushCo Holdings

/

+

Greenlane continues to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

KSHB KushCo Holdings
/

+

GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

04/02/21 Canaccord
Greenlane price target raised to $6 from $4 at Canaccord
04/01/21 Roth Capital
Greenlane price target raised to $8 from $5 at Roth Capital
03/31/21 Roth Capital
Roth Capital views KushCo, Greenlane merger combination 'favorably'
KSHB KushCo Holdings
/

+

04/02/21 Canaccord
Greenlane price target raised to $6 from $4 at Canaccord
04/01/21 Roth Capital
Greenlane price target raised to $8 from $5 at Roth Capital
03/31/21 Roth Capital
Roth Capital views KushCo, Greenlane merger combination 'favorably'
03/01/21 Alliance Global Partners
Virginia house passes bill to legalize adult-use cannabis, says Alliance Global
GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

Recommendations
Ardelyx price target lowered to $7 from $14 at Cantor Fitzgerald » 07:05
07/30/21
07/30
07:05
07/30/21
07:05
ARDX

Ardelyx

$1.71 /

-0.015 (-0.87%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARDX Ardelyx
$1.71 /

-0.015 (-0.87%)

ARDX Ardelyx
$1.71 /

-0.015 (-0.87%)

07/21/21 Citi
Ardelyx price target lowered to $7 from $16 at Citi
07/21/21 Jefferies
Ardelyx downgraded to Hold from Buy at Jefferies
07/20/21
Fly Intel: Top five analyst downgrades
07/20/21 Wedbush
Ardelyx downgraded to Neutral, price cut to $3 at Wedbush
ARDX Ardelyx
$1.71 /

-0.015 (-0.87%)

ARDX Ardelyx
$1.71 /

-0.015 (-0.87%)

Earnings
Church & Dwight sees Q3 adjusted EPS 70c, consensus 83c » 07:04
07/30/21
07/30
07:04
07/30/21
07:04
CHD

Church & Dwight

$86.90 /

+0.57 (+0.66%)

Sees Q3 revenue growth…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$86.90 /

+0.57 (+0.66%)

CHD Church & Dwight
$86.90 /

+0.57 (+0.66%)

07/14/21 Raymond James
Church & Dwight downgraded to Underperform from Market Perform at Raymond James
07/13/21 Raymond James
Church & Dwight downgraded to Underperform from Market Perform at Raymond James
06/23/21 UBS
Church & Dwight initiated with a Neutral at UBS
04/19/21
Fly Intel: Top five analyst downgrades
CHD Church & Dwight
$86.90 /

+0.57 (+0.66%)

CHD Church & Dwight
$86.90 /

+0.57 (+0.66%)

Hot Stocks
Bristol-Myers receives EC approval for Opdivo as treatment for GEJ cancer » 07:04
07/30/21
07/30
07:04
07/30/21
07:04
BMY

Bristol-Myers

$68.14 /

-0.6 (-0.87%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$68.14 /

-0.6 (-0.87%)

BMY Bristol-Myers
$68.14 /

-0.6 (-0.87%)

07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
07/19/21 JMP Securities
Cytokinetics price target raised to $44 from $26 at JMP Securities
BMY Bristol-Myers
$68.14 /

-0.6 (-0.87%)

BMY Bristol-Myers
$68.14 /

-0.6 (-0.87%)

BMY Bristol-Myers
$68.14 /

-0.6 (-0.87%)

BMY Bristol-Myers
$68.14 /

-0.6 (-0.87%)

Earnings
Greenlane reports preliminary Q2 revenue $34.5M, consensus $36.27M » 07:04
07/30/21
07/30
07:04
07/30/21
07:04
GNLN

Greenlane

$3.68 /

+0.02 (+0.55%)

Sees gross margin of 21%…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

04/02/21 Canaccord
Greenlane price target raised to $6 from $4 at Canaccord
04/01/21 Roth Capital
Greenlane price target raised to $8 from $5 at Roth Capital
03/31/21 Roth Capital
Roth Capital views KushCo, Greenlane merger combination 'favorably'
GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

GNLN Greenlane
$3.68 /

+0.02 (+0.55%)

Recommendations
S&P Global price target raised to $475 from $450 at Deutsche Bank » 07:04
07/30/21
07/30
07:04
07/30/21
07:04
SPGI

S&P Global

$423.65 /

+12.2 (+2.97%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPGI S&P Global
$423.65 /

+12.2 (+2.97%)

SPGI S&P Global
$423.65 /

+12.2 (+2.97%)

07/15/21 Deutsche Bank
S&P Global price target raised to $450 from $435 at Deutsche Bank
07/08/21 Morgan Stanley
S&P Global price target raised to $476 from $460 at Morgan Stanley
07/07/21 RBC Capital
S&P Global initiated with an Outperform at RBC Capital
07/07/21 Raymond James
S&P Global price target raised to $443 from $410 at Raymond James
SPGI S&P Global
$423.65 /

+12.2 (+2.97%)

SPGI S&P Global
$423.65 /

+12.2 (+2.97%)

SPGI S&P Global
$423.65 /

+12.2 (+2.97%)

Earnings
Dana backs FY21 adjusted EPS view $2.10-$2.60, consensus $2.47 » 07:04
07/30/21
07/30
07:04
07/30/21
07:04
DAN

Dana

$23.88 /

+0.81 (+3.51%)

Backs FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DAN Dana
$23.88 /

+0.81 (+3.51%)

DAN Dana
$23.88 /

+0.81 (+3.51%)

07/15/21 Deutsche Bank
Dana price target lowered to $33 from $34 at Deutsche Bank
04/15/21 Barclays
Barclays shuffles ratings in Auto Parts into 'summer recovery'
04/09/21 Barclays
Dana upgraded to Overweight on electrification benefits at Barclays
04/09/21 Barclays
Dana upgraded to Overweight from Equal Weight at Barclays
DAN Dana
$23.88 /

+0.81 (+3.51%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.